First results of the EORTC-GELA H9 randomized trials: the H9-F trial (comparing 3 radiation dose levels) and H9-U trial (comparing 3 chemotherapy schemes) in patients with favorable or unfavorable early stage Hodgkin’s lymphoma (HL)
暂无分享,去创建一个
E. Noordijk | M. Henry-Amar | F. Morschhauser | P. Brice | H. Eghbali | P. Carde | Pauline Brice | F. Morschhauser | Christophe Fermé | Evert M. Noordijk | J. Thomas | M. B. Van't Veer | M Divine | P. Carde | H. Eghbali | M. Henry-Amar | M. V. Veer | M. Diviné | J. Thomas | C. Fermé | Michel Henry-Amar | M. Diviné